The medications Ozempic (semaglutide), Wegovy (semaglutide) and Mounjaro (tirzepatide) continue to be in high demand as people turn to these medications for weight loss, heart health and Type 2 diabetes control. However, taking Ozempic and other GLP-1 drugs for weight loss might not be for everyone. Read More >>
Media/Press
Dr. Decotiis Contributes to NewsWeek – Map Shows America’s Healthiest Cities
America has an obesity problem, heart disease and cancer diagnoses are rising, and health care premiums are skyrocketing. But not all states or cities are equally affected. WalletHub looked at the 180 top U.S. cities across 41 indicators of good health, ranging from the cost of a medical visit to the average fruit and vegetable […]
Dr. Decotiis Contributes to NewsWeek – Demand for Weight-Loss Drugs Spikes Despite Horror Stories
Since weight loss drugs like Ozempic and Mounjaro first hit the market, patients have shared horror story symptoms and even complained of how the pounds pile back on when they stop taking the medication. Nausea, diarrhea, constipation, stomach pain and other gastrointestinal issues are just some of the common side effects listed. However, even if […]